BDH Industries Ltd (BDHI)

BDH Industries Limited engages in the manufacture and sale of therapeutic formulations covering a range of pharmaceuticals in India. It provides analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcers pharmaceutical products. The company also offers antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it provides skin protectives, skin smootheners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. The company exports its products to the United States, Canada, Latin America, the Caribbean Islands, Europe, Russia, Gulf Countries, Australia, African countries, Asia, and Far East countries. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.